E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/18/2015 in the Prospect News PIPE Daily.

eMagin plans to conduct $6 million registered direct stock offering

Deal also includes five-year warrants for 2.6 million common shares

By Devika Patel

Knoxville, Tenn., Dec. 18 – eMagin Corp. said it has arranged a $6 million registered direct offering of stock. Craig-Hallum Capital Group, LLC is the agent for the deal, which priced Dec. 17.

The company will sell 4 million common shares at $1.50 apiece. The price per share represents a 14.29% discount to the Dec. 16 closing share price of $0.35.

The investors will also receive warrants for 2.6 million shares, which are each exercisable at $2.05 for five years. The strike price is a 14.29% premium to the Dec. 16 closing share price.

Settlement is expected Dec. 23.

Proceeds will be used for working capital and general corporate purposes.

Based in Vienna, Va., Cel-Sci develops treatments for cancer and infectious diseases.

Issuer:eMagin Corp.
Issue:Common shares
Amount:$6 million
Shares:4 million
Price:$1.50
Warrants:For 2.6 million shares
Warrant expiration:Five years
Warrant strike price:$2.05
Agent:Craig-Hallum Capital Group, LLC
Pricing date:Dec. 17
Settlement date:Dec. 23
Stock symbol:Amex: CVM
Stock price:$0.35 at close Dec. 16
Market capitalization:$81.59 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.